Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy

Improved understanding of microRNA expression and function in cancer has revealed a range of microRNAs that negatively regulate many oncogenic pathways, thus representing potent tumor suppressors. Therapeutic targeting of the expression of these microRNAs to the site of tumors and metastases provide...

Full description

Bibliographic Details
Main Authors: Clodagh P. O’Neill, Róisín M. Dwyer
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/2/521
id doaj-bfba94e7ffc3467aa0747a7509e3fc77
record_format Article
spelling doaj-bfba94e7ffc3467aa0747a7509e3fc772020-11-25T02:09:20ZengMDPI AGCells2073-44092020-02-019252110.3390/cells9020521cells9020521Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer TherapyClodagh P. O’Neill0Róisín M. Dwyer1Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, H91 YR71 Galway, IrelandDiscipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, H91 YR71 Galway, IrelandImproved understanding of microRNA expression and function in cancer has revealed a range of microRNAs that negatively regulate many oncogenic pathways, thus representing potent tumor suppressors. Therapeutic targeting of the expression of these microRNAs to the site of tumors and metastases provides a promising avenue for cancer therapy. To overcome challenges associated with microRNA degradation, transient expression and poor targeting, novel nanoparticles are being developed and employed to shield microRNAs for tumor-targeted delivery. This review focuses on studies describing a variety of both natural and synthetic nanoparticle delivery vehicles that have been engineered for tumor-targeted delivery of tumor suppressor microRNAs in vivo.https://www.mdpi.com/2073-4409/9/2/521tumor suppressor mirnacancer therapynanoparticle delivery
collection DOAJ
language English
format Article
sources DOAJ
author Clodagh P. O’Neill
Róisín M. Dwyer
spellingShingle Clodagh P. O’Neill
Róisín M. Dwyer
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
Cells
tumor suppressor mirna
cancer therapy
nanoparticle delivery
author_facet Clodagh P. O’Neill
Róisín M. Dwyer
author_sort Clodagh P. O’Neill
title Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
title_short Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
title_full Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
title_fullStr Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
title_full_unstemmed Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
title_sort nanoparticle-based delivery of tumor suppressor microrna for cancer therapy
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2020-02-01
description Improved understanding of microRNA expression and function in cancer has revealed a range of microRNAs that negatively regulate many oncogenic pathways, thus representing potent tumor suppressors. Therapeutic targeting of the expression of these microRNAs to the site of tumors and metastases provides a promising avenue for cancer therapy. To overcome challenges associated with microRNA degradation, transient expression and poor targeting, novel nanoparticles are being developed and employed to shield microRNAs for tumor-targeted delivery. This review focuses on studies describing a variety of both natural and synthetic nanoparticle delivery vehicles that have been engineered for tumor-targeted delivery of tumor suppressor microRNAs in vivo.
topic tumor suppressor mirna
cancer therapy
nanoparticle delivery
url https://www.mdpi.com/2073-4409/9/2/521
work_keys_str_mv AT clodaghponeill nanoparticlebaseddeliveryoftumorsuppressormicrornaforcancertherapy
AT roisinmdwyer nanoparticlebaseddeliveryoftumorsuppressormicrornaforcancertherapy
_version_ 1724924436801388544